-
(2R,3R,4R,5S)-1-Butyl-2-(hydroxymethyl)piperidine-3,4,5-triol
-
BD14377572599-27-098%
-
¥1841.0100mg
-
(S)-Quinuclidin-3-yl (2-(2-(4-fluorophenyl)thiazol-4-yl)propan-2-yl)carbamate
-
BD4459771401090-53-698%
-
¥2189.050mg
-
(2R,3R,4R,5S)-1-Butyl-2-(hydroxymethyl)piperidine-3,4,5-triol hydrochloride
-
BD143776210110-90-098%
-
¥776.025mg
-
N-((1R,2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-(pyrrolidin-1-yl)propan-2-yl)octanamide
-
BD251315491833-29-598%
-
¥1021.0100mg
-
N-((1R,2R)-1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-(pyrrolidin-1-yl)propan-2-yl)octanamide ((2R,3R)-2,3-dihydroxysuccinate)(2:1)
-
BD434864928659-70-598%
-
¥1362.0100mg
-
(2R,3R,4R,5S)-1-(Butyl-d9)-2-(hydroxymethyl)piperidine-3,4,5-triol hydrochloride
-
BD014585361883545-57-095% +98%atom%D
-
¥2785.01mg
-
N-(4-(2-Hydroxypropan-2-yl)phenyl)-3-oxo-2-(2-(2,2,2-trifluoroethoxy)phenyl)-2,3-dihydropyridazine-4-carboxamide
-
BD014583292597958-02-498%
-
¥
-
Glucosylceramide synthase-IN-1
-
BD015289842601393-20-698%
-
¥
-
G43-C3-TEG
-
BD022966192702262-15-398%
-
¥
-
Ibiglustat succinate
-
BD014501451629063-80-498+%
-
¥
-
Glucosylceramide synthase-IN-3
-
BD015373423029827-91-398%
-
¥
-
(2S,3R,4R,5S)-2-(Hydroxymethyl)-1-pentylpiperidine-3,4,5-triol
-
BD01425958441061-33-2
-
¥92300.0100mg
-
(2S,3R,4R,5S)-1-(5-((2-Fluoro-[1,1'-biphenyl]-4-yl)methoxy)pentyl)-2-(hydroxymethyl)piperidine-3,4,5-triol
-
BD018457131633666-49-598%
-
¥6115.05mg
-
(S)-Quinuclidin-3-yl (2-(2-(4-fluorophenyl)thiazol-4-yl)propan-2-yl)carbamate (S)-2-hydroxysuccinate
-
BD010996771629063-78-098%
-
¥
-
Cedrelone
-
BD2987411254-85-998+%
-
¥2805.05mg
-
G43
-
BD01838285690693-02-898%
-
¥